BIFIDO Co. Ltd.
BIFIDO Co., Ltd. was founded in 1999, in a spirit of challenge to pursue the best biotechnology and try to be the best in the field of human microbiome. Among various intestinal microbiome, Bifidobacterium is considered to be the most beneficial bacteria to maintain healthy intestinal microbial balance.
BIFIDO has focused on research and development of Bifidobacterium spp. since 1999. Over 178 of concerning scientific papers and 70 patents prove that BIFIDO is the top-tier company with the greatest experience and expertise in microbiome industry.
Recently, BIFIDO started microbiome research on rheumatoid arthritis(RA), a chronic inflammatory disease. We analyzed the microbiota of RA patients and tried to find a way to treat even those who were less responsive to treatment. We have selected novel Bifidobacterium strains which can support healthy joints animal model and we expect a new pharmabiotics from those strains. We are now expanding our pipelines for other immune-related diseases including cancer.
BIFIDO Research Center was founded to find new health-promoting probiotics and functional ingredients, which are applied to probiotics for human, pet, oral health and cosmetics.
BIFIDO Research Center is working with various research networks including Prof. Geun Eog Ji’s laboratory at Seoul National University and other research teams. Based on continuous and dedicated research in the area of intestinal microbiome and especially, Bifidobacteria over 30 years, we have firmly established our business in probiotics and pharmabiotics area.
We produce raw materials of various selected probiotics and fermented ginseng products by our own technology and our main business is production and sales of own brand ‘ZIGUNUK’ and technical support to supply OEM/ODM products.
- BIFIDUS BGN4
- BIFIDUS BORI
- BIFIDUS AD031
- BIFIDUS AS60
- Probiotics PAI
- Probiotics GNL
- ZK Fermented Ginseng
- Pre-Mix Probiotics GNL
- Fermented Ginseng